OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

Zainab Shinkafi-Bagudu: Hannatu Ayuba Received Recognition at the OncoDaily Yvonne Award Night

Bishal Gyawali: Deescalation Trials do Not Need to be Non Inferiority

Phase 3 ARANOTE Trial: Darolutamide Plus ADT in Black Patients With Metastatic Hormone-Sensitive Prostate Cancer

Tedros Adhanom Ghebreyesus: Zero Deaths From Cervical Cancer Among Vaccinated Woman

Oncology News, Insights, Stories by OncoDaily

Garo Armen
Opinion

Speed and Rigor Are Not in Conflict - Garo Armen

Healing Through Storytelling: Practical Tools for Survivor-Led Change – An OncoDaily Session at SIOP 2026
OncoDaily

Healing Through Storytelling: Practical Tools for Survivor-Led Change – An OncoDaily Session at SIOP 2026

Legend Biotech
Oncolibrary

Legend Biotech Highlights Early LB2501 Data at EHA 2026

European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors

FDA Launches Operation TrialBlazer to Accelerate and Modernize Clinical Development 2026

20 Posts Not To Miss From ESMOGynae26

China Approves Satri-cel, the World’s First CAR-T Therapy for Solid Tumors

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Marco Donia: How Well Do Melanoma Trial Results Predict Routine-Care Outcomes?

Humaid Al-Shamsi: India Recently Achieved a Major Milestone in Cancer Genomics with US FDA

Voices
Aman Chauhan

Aman Chauhan Engages More Than 200 Students in a Discussion on Oncology

SIOP 2026 to Showcase the Latest Advances in Paediatric Oncology - AIEOP

Jason Yongsheng Chan: What Do You Know About Sarcoma and Skin Cancer?

Annie Wong: Inspired by the Women’s Networking Session at ASCO Breakthrough

Hesham ElGhazaly Shortlisted for the UICC Board of Directors

Highlights From the Recent Multidisciplinary Masterclass - European School of Oncology

Coping with Grief and Hospital Avoidance during Rhabdomyosarcoma Treatment - SIOP

FDA Approvals
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

3rd Synergies Forum on Cancer: Policy, Research and Funding Strategies

Hellenic Cancer Federation (ELLOK)

29 Jun
3rd Synergies Forum on Cancer

European School of Oncology's Basic Principles in Oncology Course

European School of Oncology (ESO) College

04 Dec
Oncology

ESO's Multidisciplinary Masterclass in Oncology - Autumn Edition

European School of Oncology (ESO) College

06 Nov
Oncology

European School of Oncology's Advanced Hands-On Course on Rectal Cancer Management

European School of Oncology (ESO) College

27 Nov
Rectal Cancer

European School of Oncology's Basics in Breast Cancer Surgery

European School of Oncology (ESO) College

09 Oct
Oncology

Immune-oncology
New Biomarkers for Immunotherapy Success in Metastatic Kidney Cancer

New Biomarkers for Immunotherapy Success in Metastatic Kidney Cancer

HYPERPROG Study: Hyperprogressive Disease After Immune Checkpoint Inhibitors

GT-20 Trial: Personalized Neoantigen Vaccines for Glioblastoma

Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma

OCEANUS Study: Combination of Radiotherapy and Immunotherapy in Advanced NSCLC

Sipuleucel-T With or Without IL-7 in mCRPC: FDG PET/CT Offers Early Imaging Insights

Immunotherapy in Head and Neck Cancer

Gastrointestinal-Oncology
Daraxonrasib Alan Sandler

Daraxonrasib at ASCO 2026: The Pancreatic Cancer Moment That Brought the Room to Its Feet

10 Must-Read Posts In GI Oncology This Week

PancreaSure 5-Biomarker Panel for Early and Advanced PDAC Detection

ASCO 2026 Highlights by GI Cancers Alliance: What’s New in Stomach Cancer Care

Practice-Changing and Promising Trials in GI Oncology From ASCO 2026

ERRFI1 Mutations May Define an Actionable Subset of Biliary Tract Cancers

Fostrox Plus Lenvatinib Shows Encouraging Activity as Second-Line Therapy in Advanced Hepatocellular Carcinoma

Breast-Oncology
Trodelvy

European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors

SACI-IO HR+ Trial: 5 Promising Findings in Metastatic Breast Cancer

HER2-Low Status Linked to Shorter PFS With First-Line CDK4/6 Inhibitors in HR-Positive Metastatic Breast Cancer

HER2-Low Subclones Drive T-DXd Resistance in HER2-Heterogeneous Breast Cancer Models

Thermal Ablation Shows Promise in Early-Stage Breast Cancer, but Evidence Remains Limited

10 Essential Breast Oncology Posts You Can’t Miss This Week

EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer

Lung-Oncology
CT Scan

Can a Routine CT Scan Predict PD-L1 Expression in Metastatic NSCLC?

TROP2 Targeting May Delay EGFR-TKI Resistance in EGFR-Mutant NSCLC

Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR and MET Targeting

Maintenance Pemetrexed May Not Improve Survival With Pembrolizumab in Advanced Nonsquamous NSCLC

ARTIMES AI Volumetry May Improve Response Assessment in Pleural Mesothelioma

10 Essential Lung Cancer Posts You Can’t Miss This Week

LAGOON Trial: 3 Critical Results From Zepzelca in Second-Line SCLC

OncoDaily TV
Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Not To Miss
ESMOGynae26

20 Posts Not To Miss From ESMOGynae26

15 Posts Not To Miss From ESCardioOnco26

Top Growing Medical Universities in Latin America: 2026 Edition by BIGR

15 Posts Not to Miss from ESMO TAT Asia 2026

25 Posts Not To Miss From EHA 2026, Part 3

25 Posts Not To Miss From EHA 2026, Part 2

25 Posts Not To Miss From EHA 2026

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
DLBCL NHL

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

CancerWorld

Oncologists
Gilberto Lopes

Gilberto Lopes

Oncologists Location Miami, USA
Yousef Zakharia

Yousef Zakharia

Oncologists Location Red Wing, USA
Katherine Van Loon

Katherine Van Loon

Oncologists Location San Francisco, USA
Jennifer Marks

Jennifer Marks

Oncologists Location Boston, USA
Sara Tolaney

Sara Tolaney

Oncologists Location Boston, USA
Karima Oualla

Karima Oualla

Oncologists Location Fès, Morocco
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria
Abeid Athman Omar

Abeid Athman Omar

Oncologists Location Nairobi, Kenya

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

OncoDaily Medical Journal

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research